New Institute to Study Obesity, Diabetes and Other Metabolic Disorders
News Aug 29, 2008
Led by co-directors Professors Steve O’Rahilly and Nick Wareham, the IMS aspires to become a world-leading centre focused on understanding the biological basis of diabetes, obesity and related disorders and translating those scientific discoveries into improved patient care and disease prevention.
Professor Steve O’Rahilly, co-director of the Institute said:
“Obesity is one of the fastest growing epidemics in the world, and it is increasing rapidly, including in vulnerable groups such as children and individuals living in the developing world.’’
“As obesity increases the incidence of not only diabetes but heart disease and cancer as well, the implications on public health are significant. The new Institute will enable us to bring together scientists and clinicians to focus on obesity, diabetes and other metabolic diseases, which pose a growing threat to the public.”
A major aim of the Institute is to encourage daily interaction between basic and clinical scientists, epidemiologists and clinicians to maximise the impact of research into the prevention and treatment of these diseases and to improve the quality of patient care.
Housed in a new facility on the Cambridge Biomedical Campus, the IMS brings together the Metabolic Research Laboratories (MRL) of the University of Cambridge, the MRC Epidemiology Unit, the Wolfson Diabetes and Endocrine Clinic and the Weston Centre for Childhood and Adolescent Diabetes and Endocrinology.
Researchers at the MRL (directed by Professor Stephen O’Rahilly) undertake laboratory and clinical research into a range of metabolic and endocrine diseases. The MRL also hosts the new MRC Centre for Translational Research in Obesity and Related Metabolic Diseases.
The MRC Epidemiology Unit, (directed by Professor Nick Wareham) uses epidemiological methods to understand determinants of obesity and diabetes and to translate this understanding into preventive strategies.
The two clinical areas, the Wolfson Diabetes and Endocrinology Clinic and the Weston Centre for Childhood and Adolescent Diabetes and Endocrinology, provide state of the art facilities for the treatment of people of all ages with diabetes, obesity and related disorders.
Professor Nick Wareham said:
“The obesity epidemic is bringing with it a rise in the occurrence of type 2 diabetes. This disease arises from an interaction between the lifestyles we lead and our susceptibility to the condition as a result of our genetic background and early development. In addition to working together across scientific disciplines to understand these interactions, scientists within our Institute are developing and evaluating strategies aimed at preventing these chronic diseases.”
Huntsman Cancer Institute Joins National Clinical Trial Targeting AMLNews
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society (LLS). The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.READ MORE
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018